Oval Medical raises cash, reports positive study results

Oval Medical Technologies, a medical device start-up based in the U.K., has raised another stack of cash and announced positive results for a trial that compares its novel autoinjector with two well-known devices already on the market. According to the company, several large drugmakers have shown "substantial interest" in working with Oval and are undertaking feasibility studies to assess using the company's technology for a variety of injectable drugs, Ben Fountain of Cabume reports. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.